This work examines the requirements for patentability in the context of biotechnology, with a special focus on the non-obviousness requirement. It analyses non-obviousness as applied to biotechnology molecular products via a review of the relevant case law. The work begins with a typology of recombinant inventions, useful in determining ultimate non-obviousness and patentability. It distinguishes three categories of recombinant products: 'Translation' inventions, obtained by entering a known molecular information into a known process 'Molecular modification' products, obtained by modifying prior art molecules 'Combination' inventions, obtained by combining several known functional molecular units. Recognizing the risk that many translation. Patenting the Recombinant Products of Biotechnology and Other Molecules. ISBN:9789041106988 Written by: Phillipe G. Ducor.